AS

Avish Sharma

Active Director Director DIN 08861074
DIN 08861074 First appointment Sep 2020 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2020
Shareholding value •••• Premium profile

About Avish Sharma

Data last updated:

Avish Sharma is a Director at Immunescience Industries Private Limited (since 2020). The company operates in Healthcare. Immunescience Industries Private Limited reported revenue of ₹2.64 Cr (FY 2025).

DIN 08861074
Primary Designation Director
Industry Healthcare
First Appointment 03 Sep 2020
Oldest Company Age 6 yrs
Largest company Immunescience Industries Private Limited · ₹2.64 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Sep 20202020₹2.64 Cr (FY 2025)Active

Board colleagues of Avish Sharma

NameDINCompanyDesignation
Sunita Sharma08861075Immunescience Industries Private LimitedDirector

Directorship timeline

Open interactive timeline →
Immunescience Industries Private Limited
Premium access

Shareholding and investment profile for Avish Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Avish Sharma

Avish Sharma currently holds 1 directorship: Immunescience Industries Private Limited (Director, since 03 Sep 2020, revenue ₹2.64 Cr (FY 2025)).

Avish Sharma was first appointed on 03 Sep 2020 as Director at Immunescience Industries Private Limited.

The current boards of Avish Sharma's companies include Sunita Sharma (Immunescience Industries Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available